MIGUEL
ARRABAL MARTÍN
PROFESOR TITULAR DE UNIVERSIDAD
Istinye University
Estambul, TurquíaPublicaciones en colaboración con investigadores/as de Istinye University (1)
2024
-
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes
Journal of Clinical Oncology, Vol. 42, Núm. 9, pp. 987-993